| Trial registration number
|
NCT05507372 |
Full text link
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05507372
|
First author
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
Andy Goren, MD
|
Contact
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
andyg@appliedbiology.com
|
Registration date
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
2022-08-19
|
Recruitment status
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
Not recruiting
|
Study design
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
unclear
|
Study aim
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
Long covid
|
Inclusion criteria
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
diagnosed with subjective tinnitus post covid-19
tinnitus persists for at least 4 weeks
prior history of mild or no tinnitus
18 years or older
any gender
females of child bearing age must be on contraception
|
Exclusion criteria
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
pregnant
patients who participated in any interventional studies in the past 6 months
patients with severe hepatic impairment on admission (alanine aminotransferase higher than fivefold the upper limit)
patients taking any dopamine receptor antagonists
patient having history of hypersensitivity to pimozide
patients unable to comply with the study schedule
actively using cortiocosteroids
|
Number of arms
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
Applied Biology, Inc.
|
Inclusion age min
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
None
|
Type of patients
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
Patients recovered from covid
|
Severity scale
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
50
|
primary outcome
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
Tinnitus Handicap Inventory (THI)
|
Notes
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Aug. 20, 2022, 7:30 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "nan", "treatment_id": 2467, "treatment_name": "Pimozide", "treatment_type": "Central nervous system agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|